Global Ear and Nasal Packing Market Analysis, Companies Profiles, Size, Share, Growth, Trends and Forecast to 2024
The Global Ear and Nasal Packing Market is accounted to reach USD 257.32 million by 2024 from USD 168.14 million in 2016,it is growing at a CAGR of 5.6%.
The major factors driving the market are growth in the aging population and rise in the healthcare expenditure of North America soft tissue repair market. The soft tissue repair market in the North America region is leading in U.S.
The key market players for Global Ear and Nasal Packing Market are listed below:
On the basis of material, global ear and nasal packing market is segmented into bioresorbable and non-absorbable. In 2017, bioresorbable segment is expected to dominate the global ear and nasal packing’s market with 69.9% market share and is expected to reach USD 184.44 million by 2024, with the highest CAGR of 5.9% in the forecast period 2017 to 2024.
On the basis of end user, the ear and nasal packing market is segmented into hospital, clinics, ambulatory centers and others. In 2017, hospital segment is expected to dominate the market, expected to reach USD XX million by 2024, growing at the highest CAGR of 6.2% in the forecast period.
On the basis of distribution channel, the ear and nasal packing market is segmented into direct tenders and over the counter. The direct tender is expected to dominate the global ear and nasal packing market with 65.2% market share, growing at the highest CAGR 6.0% in the forecast period 2017 to 2024.
Based on geography, the Global Ear and Nasal Packing market is segmented into geographical regions, such as,
The report covers the present scenario and the growth prospects of the Global Ear and Nasal Packing market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of the web conferencing and unified communication and collaboration (UC&C) and video conferencing, secondary resources and doing in-depth company share analysis of major 10 players in the market.
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
The major factors driving the market are growth in the aging population and rise in the healthcare expenditure of North America soft tissue repair market. The soft tissue repair market in the North America region is leading in U.S.
The key market players for Global Ear and Nasal Packing Market are listed below:
- Stryker and Smith
- Nephew
- Summit Medical Group,
- Entellus Medical, Inc.,
- Olympus Corporation,
- Network Medical Products Ltd.,
- Lohmann & Rauscher GmbH & Co. KG
- DCC plc
- Type
- Material
- End User
- Geography
On the basis of material, global ear and nasal packing market is segmented into bioresorbable and non-absorbable. In 2017, bioresorbable segment is expected to dominate the global ear and nasal packing’s market with 69.9% market share and is expected to reach USD 184.44 million by 2024, with the highest CAGR of 5.9% in the forecast period 2017 to 2024.
On the basis of end user, the ear and nasal packing market is segmented into hospital, clinics, ambulatory centers and others. In 2017, hospital segment is expected to dominate the market, expected to reach USD XX million by 2024, growing at the highest CAGR of 6.2% in the forecast period.
On the basis of distribution channel, the ear and nasal packing market is segmented into direct tenders and over the counter. The direct tender is expected to dominate the global ear and nasal packing market with 65.2% market share, growing at the highest CAGR 6.0% in the forecast period 2017 to 2024.
Based on geography, the Global Ear and Nasal Packing market is segmented into geographical regions, such as,
- North America,
- Europe,
- APAC,
- South America,
- Middle East
- Africa
The report covers the present scenario and the growth prospects of the Global Ear and Nasal Packing market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of the web conferencing and unified communication and collaboration (UC&C) and video conferencing, secondary resources and doing in-depth company share analysis of major 10 players in the market.
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
1 INTRODUCTION
1.1. OVERVIEW OF THE EAR AND NASAL PACKING MARKET
1.2. MARKET SEGMENTATION & COVERAGE
1.2.1. CURRENCY AND PRICING
1.2.2. LIMITATION
1.2.3. STAKEHOLDERS
2. RESEARCH METHODOLOGY
2.1. KEY TAKEAWAYS
2.2. ARRIVING AT THE EAR AND NASAL PACKING SIZE
2.2.1. MARKET CRACKDOWN APPROACH
2.2.2. COMPANY REVENUE AND MARKET SHARE ANALYSIS
2.2.3. DATA TRIANGULATION
2.2.4. KEY DATA POINTS FROM PRIMARY SOURCES
2.2.5. KEY DATA POINTS FROM SECONDARY SOURCES
2.2.6. PORTER’S FIVE FORCES MATRIX
2.3. GLOBAL EAR AND NASAL PACKING MARKET: RESEARCH SNAPSHOT
2.4. ASSUMPTIONS
3. MARKET LANDSCAPE SUMMARY
4. PREMIUM INSIGHTS
4.1. OVERVIEW
4.2. GLOBAL EAR AND NASAL PACKING MARKET: KEY PRIMARY INSIGHTS
4.3. MARKET OVERVIEW
4.3.1. DRIVERS
4.3.1.1. HIGH PREVALENCE OF CHRONIC SINUSITIS
4.3.1.2. GROWING ADOPTION OF MINIMALLY INVASIVE PROCEDURES
4.3.1.3. TECHNOLOGICAL DEVELOPEMENTS
4.3.1.4. FAVOURABLE REIMBURSEMENTS
4.3.2. RESTRAINTS
4.3.3. OPPURTUNITIES
4.3.4. THREATS
4.4. KEY MARKET TRENDS AND UPCOMING TECHNOLOGIES
5. EXECUTIVE SUMMARY
6. EAR AND NASAL PACKING MARKET, BY TYPE
6.1. OVERVIEW
6.2. NASAL PACKING, BY PRODUCT TYPE (2014 – 2022)
6.2.1. INJECTABLE
6.2.2. GEL
6.2.3. DRESSINGS, BY PRODUCT TYPE
6.2.3.1. SPONGES
6.2.3.2. SPLINTS
6.2.3.3. STRIPS
6.2.3.4. OTHERS
6.3. EAR PACKING, BY PRODUCT TYPE (2014 – 2022)
6.3.1. INJECTABLE
6.3.2. GEL
6.3.3. DRESSINGS, BY PRODUCT TYPE
6.3.3.1. SPONGES
6.3.3.2. SPLINTS
6.3.3.3. STRIPS
7. EAR AND NASAL PACKING MARKET, BY MATERIAL
7.1. OVERVIEW
7.2. BIORESORBABLE, BY MATERIAL
7.2.1. CHITOSAN
7.2.2. HYAFF (HYALURONIC ACID)
7.2.3. COMBINATION
7.3. NON-ABSORBABLE
7.3.1. CMC (CARBOXYMETHYL CELLULOSE)
7.3.2. SYNTHETIC
7.3.3. OTHERS
8. EAR AND NASAL PACKING MARKET, BY END USER
8.1. OVERVIEW
8.2. HOSPITAL
8.3. CLINICS
8.4. AMBULATORY CENTERS
8.5. OTHERS
9. EAR AND NASAL PACKING MARKET, BY DISTRIBUTION CHANNEL
9.1. OVERVIEW
9.2. DIRECT TENDER
9.3. OVER THE COUNTER
10. EAR AND NASAL PACKING MARKET, BY GEOGRAPHY
10.1. COUNTRYWISE EAR AND NASAL PACKING MARKET, (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)
10.1.1. NORTH AMERICA
10.1.1.1. U.S.
10.1.1.2. CANADA
10.1.1.3. MEXICO
10.1.2. EUROPE
10.1.2.1. GERMANY
10.1.2.2. FRANCE
10.1.2.3. U.K.
10.1.2.4. ITALY
10.1.2.5. SPAIN
10.1.2.6. RUSSIA
10.1.2.7. TURKEY
10.1.2.8. BELGIUM
10.1.2.9. NETHERLANDS
10.1.2.10. SWITZERLAND
10.1.2.11. REST OF EUROPE
10.1.3. ASIA-PACIFIC (APAC)
10.1.3.1. JAPAN
10.1.3.2. CHINA
10.1.3.3. SOUTH KOREA
10.1.3.4. INDIA
10.1.3.5. AUSTRALIA
10.1.3.6. SINGAPORE
10.1.3.7. THAILAND
10.1.3.8. MALAYSIA
10.1.3.9. INDONESIA
10.1.3.10. PHILIPPINES
10.1.3.11. REST OF APAC
10.1.4. SOUTH AMERICA
10.1.4.1. BRAZIL
10.1.4.2. REST OF LATIN AMERICA
10.1.5. MIDDLE EAST AND AFRICA
10.1.5.1. SOUTH AFRICA
10.1.5.2. REST OF MIDDLE EAST AND AFRICA
10.2. KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES
11. EAR AND NASAL PACKING MARKET: COMPETITIVE LANDSCAPE
11.1. GLOBAL EAR AND NASAL PACKING MARKET: COMPANY SHARE ANALYSIS
11.2. U.S. EAR AND NASAL PACKING MARKET: COMPANY SHARE ANALYSIS
11.3. MERGERS & ACQUISITIONS
11.4. NEW PRODUCT DEVELOPMENT & APPROVALS
11.5. EXPANSIONS
11.6. REGULATORY CHANGES
11.7. PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS
12. EAR AND NASAL PACKING MARKET, COMPANY PROFILES
12.1. MEDTRONIC
12.1.1. OVERVIEW
12.1.2. SWOT ANALYSIS
12.1.3. PRODUCT PORTFOLIO
12.1.4. REVENUE ANALYSIS
12.1.5. ANALYSTS VIEW
12.2. STRYKER
12.2.1. OVERVIEW
12.2.2. SWOT ANALYSIS
12.2.3. PRODUCT PORTFOLIO
12.2.4. REVENUE ANALYSIS
12.2.5. ANALYSTS VIEW
12.3. SUMMIT MEDICAL
12.3.1. OVERVIEW
12.3.2. SWOT ANALYSIS
12.3.3. PRODUCT PORTFOLIO
12.3.4. REVENUE ANALYSIS
12.3.5. ANALYST VIEW
12.4. SMITH AND NEPHEW
12.4.1. OVERVIEW
12.4.2. SWOT ANALYSIS
12.4.3. PRODUCT PORTFOLIO
12.4.4. REVENUE ANALYSIS
12.4.5. ANALYSTS VIEW
12.5. ENTELLUS MEDICAL, INC.
12.5.1. OVERVIEW
12.5.2. SWOT ANALYSIS
12.5.3. PRODUCT PORTFOLIO
12.5.4. REVENUE ANALYSIS
12.5.5. ANALYSTS VIEW
12.6. OLYMPUS MEDICAL
12.6.1. OVERVIEW
12.6.2. SWOT ANALYSIS
12.6.3. PRODUCT PORTFOLIO
12.6.4. REVENUE ANALYSIS
12.6.5. ANALYSTS VIEW
12.7. BOSTON MEDICAL PRODUCTS, INC.
12.7.1. OVERVIEW
12.7.2. SWOT ANALYSIS
12.7.3. PRODUCT PORTFOLIO
12.7.4. REVENUE ANALYSIS
12.7.5. ANALYSTS VIEW
12.8. LOHMANN & RAUSCHER
12.8.1. OVERVIEW
12.8.2. SWOT ANALYSIS
12.8.3. PRODUCT PORTFOLIO
12.8.4. REVENUE ANALYSIS
12.1.5. ANALYSTS VIEW
12.9. NETWORK MEDICAL PRODUCTS LTD.
12.9.1. OVERVIEW
12.9.2. SWOT ANALYSIS
12.9.3. PRODUCT PORTFOLIO
12.9.4. REVENUE ANALYSIS
12.9.5. ANALYSTS VIEW
12.10. FANNIN
12.10.1. OVERVIEW
12.10.2. SWOT ANALYSIS
12.10.3. PRODUCT PORTFOLIO
12.10.4. REVENUE ANALYSIS
12.10.5. ANALYSTS VIEW
13. APPENDIX
14. ABOUT DATA BRIDGE MARKET RESEARCH
1.1. OVERVIEW OF THE EAR AND NASAL PACKING MARKET
1.2. MARKET SEGMENTATION & COVERAGE
1.2.1. CURRENCY AND PRICING
1.2.2. LIMITATION
1.2.3. STAKEHOLDERS
2. RESEARCH METHODOLOGY
2.1. KEY TAKEAWAYS
2.2. ARRIVING AT THE EAR AND NASAL PACKING SIZE
2.2.1. MARKET CRACKDOWN APPROACH
2.2.2. COMPANY REVENUE AND MARKET SHARE ANALYSIS
2.2.3. DATA TRIANGULATION
2.2.4. KEY DATA POINTS FROM PRIMARY SOURCES
2.2.5. KEY DATA POINTS FROM SECONDARY SOURCES
2.2.6. PORTER’S FIVE FORCES MATRIX
2.3. GLOBAL EAR AND NASAL PACKING MARKET: RESEARCH SNAPSHOT
2.4. ASSUMPTIONS
3. MARKET LANDSCAPE SUMMARY
4. PREMIUM INSIGHTS
4.1. OVERVIEW
4.2. GLOBAL EAR AND NASAL PACKING MARKET: KEY PRIMARY INSIGHTS
4.3. MARKET OVERVIEW
4.3.1. DRIVERS
4.3.1.1. HIGH PREVALENCE OF CHRONIC SINUSITIS
4.3.1.2. GROWING ADOPTION OF MINIMALLY INVASIVE PROCEDURES
4.3.1.3. TECHNOLOGICAL DEVELOPEMENTS
4.3.1.4. FAVOURABLE REIMBURSEMENTS
4.3.2. RESTRAINTS
4.3.3. OPPURTUNITIES
4.3.4. THREATS
4.4. KEY MARKET TRENDS AND UPCOMING TECHNOLOGIES
5. EXECUTIVE SUMMARY
6. EAR AND NASAL PACKING MARKET, BY TYPE
6.1. OVERVIEW
6.2. NASAL PACKING, BY PRODUCT TYPE (2014 – 2022)
6.2.1. INJECTABLE
6.2.2. GEL
6.2.3. DRESSINGS, BY PRODUCT TYPE
6.2.3.1. SPONGES
6.2.3.2. SPLINTS
6.2.3.3. STRIPS
6.2.3.4. OTHERS
6.3. EAR PACKING, BY PRODUCT TYPE (2014 – 2022)
6.3.1. INJECTABLE
6.3.2. GEL
6.3.3. DRESSINGS, BY PRODUCT TYPE
6.3.3.1. SPONGES
6.3.3.2. SPLINTS
6.3.3.3. STRIPS
7. EAR AND NASAL PACKING MARKET, BY MATERIAL
7.1. OVERVIEW
7.2. BIORESORBABLE, BY MATERIAL
7.2.1. CHITOSAN
7.2.2. HYAFF (HYALURONIC ACID)
7.2.3. COMBINATION
7.3. NON-ABSORBABLE
7.3.1. CMC (CARBOXYMETHYL CELLULOSE)
7.3.2. SYNTHETIC
7.3.3. OTHERS
8. EAR AND NASAL PACKING MARKET, BY END USER
8.1. OVERVIEW
8.2. HOSPITAL
8.3. CLINICS
8.4. AMBULATORY CENTERS
8.5. OTHERS
9. EAR AND NASAL PACKING MARKET, BY DISTRIBUTION CHANNEL
9.1. OVERVIEW
9.2. DIRECT TENDER
9.3. OVER THE COUNTER
10. EAR AND NASAL PACKING MARKET, BY GEOGRAPHY
10.1. COUNTRYWISE EAR AND NASAL PACKING MARKET, (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)
10.1.1. NORTH AMERICA
10.1.1.1. U.S.
10.1.1.2. CANADA
10.1.1.3. MEXICO
10.1.2. EUROPE
10.1.2.1. GERMANY
10.1.2.2. FRANCE
10.1.2.3. U.K.
10.1.2.4. ITALY
10.1.2.5. SPAIN
10.1.2.6. RUSSIA
10.1.2.7. TURKEY
10.1.2.8. BELGIUM
10.1.2.9. NETHERLANDS
10.1.2.10. SWITZERLAND
10.1.2.11. REST OF EUROPE
10.1.3. ASIA-PACIFIC (APAC)
10.1.3.1. JAPAN
10.1.3.2. CHINA
10.1.3.3. SOUTH KOREA
10.1.3.4. INDIA
10.1.3.5. AUSTRALIA
10.1.3.6. SINGAPORE
10.1.3.7. THAILAND
10.1.3.8. MALAYSIA
10.1.3.9. INDONESIA
10.1.3.10. PHILIPPINES
10.1.3.11. REST OF APAC
10.1.4. SOUTH AMERICA
10.1.4.1. BRAZIL
10.1.4.2. REST OF LATIN AMERICA
10.1.5. MIDDLE EAST AND AFRICA
10.1.5.1. SOUTH AFRICA
10.1.5.2. REST OF MIDDLE EAST AND AFRICA
10.2. KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES
11. EAR AND NASAL PACKING MARKET: COMPETITIVE LANDSCAPE
11.1. GLOBAL EAR AND NASAL PACKING MARKET: COMPANY SHARE ANALYSIS
11.2. U.S. EAR AND NASAL PACKING MARKET: COMPANY SHARE ANALYSIS
11.3. MERGERS & ACQUISITIONS
11.4. NEW PRODUCT DEVELOPMENT & APPROVALS
11.5. EXPANSIONS
11.6. REGULATORY CHANGES
11.7. PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS
12. EAR AND NASAL PACKING MARKET, COMPANY PROFILES
12.1. MEDTRONIC
12.1.1. OVERVIEW
12.1.2. SWOT ANALYSIS
12.1.3. PRODUCT PORTFOLIO
12.1.4. REVENUE ANALYSIS
12.1.5. ANALYSTS VIEW
12.2. STRYKER
12.2.1. OVERVIEW
12.2.2. SWOT ANALYSIS
12.2.3. PRODUCT PORTFOLIO
12.2.4. REVENUE ANALYSIS
12.2.5. ANALYSTS VIEW
12.3. SUMMIT MEDICAL
12.3.1. OVERVIEW
12.3.2. SWOT ANALYSIS
12.3.3. PRODUCT PORTFOLIO
12.3.4. REVENUE ANALYSIS
12.3.5. ANALYST VIEW
12.4. SMITH AND NEPHEW
12.4.1. OVERVIEW
12.4.2. SWOT ANALYSIS
12.4.3. PRODUCT PORTFOLIO
12.4.4. REVENUE ANALYSIS
12.4.5. ANALYSTS VIEW
12.5. ENTELLUS MEDICAL, INC.
12.5.1. OVERVIEW
12.5.2. SWOT ANALYSIS
12.5.3. PRODUCT PORTFOLIO
12.5.4. REVENUE ANALYSIS
12.5.5. ANALYSTS VIEW
12.6. OLYMPUS MEDICAL
12.6.1. OVERVIEW
12.6.2. SWOT ANALYSIS
12.6.3. PRODUCT PORTFOLIO
12.6.4. REVENUE ANALYSIS
12.6.5. ANALYSTS VIEW
12.7. BOSTON MEDICAL PRODUCTS, INC.
12.7.1. OVERVIEW
12.7.2. SWOT ANALYSIS
12.7.3. PRODUCT PORTFOLIO
12.7.4. REVENUE ANALYSIS
12.7.5. ANALYSTS VIEW
12.8. LOHMANN & RAUSCHER
12.8.1. OVERVIEW
12.8.2. SWOT ANALYSIS
12.8.3. PRODUCT PORTFOLIO
12.8.4. REVENUE ANALYSIS
12.1.5. ANALYSTS VIEW
12.9. NETWORK MEDICAL PRODUCTS LTD.
12.9.1. OVERVIEW
12.9.2. SWOT ANALYSIS
12.9.3. PRODUCT PORTFOLIO
12.9.4. REVENUE ANALYSIS
12.9.5. ANALYSTS VIEW
12.10. FANNIN
12.10.1. OVERVIEW
12.10.2. SWOT ANALYSIS
12.10.3. PRODUCT PORTFOLIO
12.10.4. REVENUE ANALYSIS
12.10.5. ANALYSTS VIEW
13. APPENDIX
14. ABOUT DATA BRIDGE MARKET RESEARCH
